Phasic approach to oral contraceptives
- 1 October 1987
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 157 (4) , 1052-1058
- https://doi.org/10.1016/s0002-9378(87)80131-x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Effect of Estrogen/Progestin Potency on Lipid/Lipoprotein CholesterolNew England Journal of Medicine, 1983
- The endocrinology of the menstrual cycle: the interaction of folliculogenesis and neuroendocrine mechanismsFertility and Sterility, 1982
- Oral Contraceptives and Cardiovascular DiseaseNew England Journal of Medicine, 1981
- Oral Contraceptives and Cardiovascular DiseaseNew England Journal of Medicine, 1981
- Lipoprotein Changes May Be Minimized by Proper Composition of a Combined Oral ContraceptiveFertility and Sterility, 1981
- Serum High-Density-Lipoprotein Cholesterol in Women Using Oral Contraceptives, Estrogens and ProgestinsNew England Journal of Medicine, 1978
- HÆMOSTATIC, LIPID, AND BLOOD-PRESSURE PROFILES OF WOMEN ON ORAL CONTRACEPTIVES CONTAINING 50 µg OR 30 µg ŒSTROGENThe Lancet, 1977
- Dose-dependent inhibition by oral contraceptives of the pituitary to release LH and FSH in response to stimulation with LH-RHContraception, 1976
- Thromboembolic Disease and the Steroidal Content of Oral Contraceptives. A Report to the Committee on Safety of DrugsBMJ, 1970